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A New Questionnaire to Determine the Frequency and Severity of Symptoms Caused by
Inhaled Odors, Chemicals and Irritants in Normal Subjects and Their Relation to HealthRelated Quality of Life
Stephen E. Williamson, M.D.
ABSTRACT
Abstract
Individuals may develop symptoms in response to inhaled odors, chemicals, and irritants.
This may affect their quality of life. Little is known about the prevalence and severity of
symptoms that result from exposure to odors, chemicals and irritants. This study
demonstrates the development of a new respiratory questionnaire to detect the prevalence
and severity of symptoms experienced upon exposure to chemicals, odors, and irritants, and
relates these symptoms to quality of life. This questionnaire was submitted to 96 volunteers
at the University of South Florida College of Public Health who responded to items
regarding symptoms developed in response to exposure to automobile exhaust, cigarette
smoke, strong smells, cologne, perfumes or scented candles, or fresh paint vapors or fumes.
Health-related quality of life was assessed using a subscale included with the questionnaire.
The number and severity of symptoms developed in response to exposure to odors,
chemicals, and irritants showed a strong negative correlation with health-related quality of
life, consistent with intuitive estimates of the direction of this relationship. Also, it was
shown that in normal populations, males and females develop statistically similar prevalence
and severity of symptoms in response to exposure to odors, chemicals, and irritants.

iv

Hypothesis and Specific Aims
Hypothesis
The frequency and severity of symptoms reported by those who are exposed to inhaled
odors, chemicals and irritants can be determined by a self-administered questionnaire, and
these symptoms affect their reported quality of life.
Specific Aims
I: To develop a self-administered questionnaire and demonstrate that it detects the
frequency and severity of symptoms reported by normal individuals on their experience with
odors, chemicals, and irritants.
II: To determine the relationship between self-reported quality of life and severity of
reported symptoms in normal individuals' experience with inhaled odors, chemicals, and
irritants.
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Introduction
Questionnaires are an important and powerful tool to explore occupational health problems.
They are easy to apply, inexpensive to administer, and readily interpretable. The proper use
of a questionnaire is dependent on careful design, subsequent verification of validity and
reproducibility, and the close monitoring of its application.1 Here, we will demonstrate the
creation of a questionnaire and its use to determine the effects of inhaled substances on
normal individuals with regard to symptoms they experience and the effect of their
symptoms on quality of life.
Many airborne chemical substances with an odor may produce sensory irritation in the eyes,
nose and throat, as well as acute neurotoxic symptoms. Such symptoms are dose related and
all persons experience them. Some persons who sense the odor from certain chemical
substances may feel ill, although this reaction is not experienced by others with the same
exposure. Irritant symptoms may arise in environments in which inhaled substances are at
levels lower than regulation levels,2 and some say that chemical sensitivity is due to
inadequate exposure limits for chemicals.3 Only a few epidemiologic studies from different
work places have been performed to study this phenomenon.4 It is important to understand
this phenomenon to protect workers properly.
Individuals may incur great personal costs in order to ease their symptoms, whatever the
cause or the current term for their symptoms or whether they incur the symptoms at home or
work. Studies have shown that workers have had to change jobs4 or are perhaps drawn or
pushed into other jobs5 because they could not tolerate the symptoms they sustain when
exposed to odors and irritants at work.
The field of odor and irritant sensitivity requires understanding the contributions of many
authors in the fields of anatomy, physiology, pathophysiology, and psychology. The
literature covering this phenomenon is huge. A basic problem facing the study of sensitivity
to inhaled substances is determining if the symptoms occur due to psychological factors or
physiological factors. Broadly, areas of investigation include olfactory physiology,
respiratory physiology, and psychology.
People are exposed to airborne substances at home and at work. Many of these substances
not only produce an odor but can evoke ocular, nasal and throat irritation, as well as
neurotoxic symptoms. It is useful to define the airborne substances of interest as odors or
irritants. Briefly, odors stimulate the olfactory nerve (cranial nerve I). Irritants cause
inflammatory effects.6 Lateralization testing demonstrates this difference. Single nostril
stimulation with an irritant causes lateralization. That is, one can tell into which nostril the
2

stimulus is applied in the case an irritant, such as ammonia. An odor, however, infused into
one nostril is sensed bilaterally.7 Many substances have odorous and irritant properties, but
not all substances that are irritating are odorous (NO2),8 and not all odorous substances are
irritating (phenyl ethyl alcohol).2 Irritant substances may be a simple molecule, such as
acrolein and ozone or a complex mixture, such as tobacco smoke.9 However, inhaled odors
and irritants can elicit complaints of eye, nose, and throat irritation, headache, nausea,
diarrhea, hoarseness, sore throat, cough, chest tightness, nasal congestion, palpitations,
shortness of breath, stress, drowsiness, and alterations in mood.8 The number of individuals
who suffer from these symptoms is not known accurately, as estimates of the prevalence of
this chemical sensitivity range from about 11 million10 to 90 million11 individuals. The
difference in prevalence is likely due to different case definitions.
The field studying sensitivity to inhaled substances suffers from the lack of a consistent case
definition or the name for phenomenon of sensitivity to inhaled substances,4 therefore, the
results of studies are difficult to compare. Odor perception is highly idiosyncratic, and this
variability affects subjective responses. Numerous factors, including adaptation,
medications, aging, nutritional status, pregnancy, and a variety of diseases and disorders can
affect odor perception. Also, disorders of the olfactory system affect over 2.7 million
Americans.7 Some of the symptoms of diseases such as asthma and allergic rhinitis overlap
those symptoms developed after exposure to odors and irritants. Furthermore, allergic
symptoms can be exacerbated by non-allergenic inhaled substances.10, 12
Although it may appear to be straightforward to expose individuals to a chemical and ask
them to report on the level of irritation they experience, the potential for confusion between
olfactory and irritant modalities has produced extreme variability in direct scaling of upper
airway irritant sensations by individuals with intact olfactory and trigeminal systems. This
confusion is exacerbated when chemicals present in the air at levels that stimulate only odor
sensation can prompt exposed individuals to report ‘irritation’, even if the perception is
largely mediated through the psychological discomfort incurred by smelling the odor of an
unfamiliar or unpleasant chemical, or even from misattributions of unrelated symptoms that
happen to coincide with chemical exposure.2 More simply, subjects may report to
researchers "irritation" by odors that are merely unpleasant or unfamiliar, so this study
design yields confusing results.
Psychologically, hypotheses have focused on psychiatric disorders, personality traits13, 14 and
mass hysteria.15 Responses to inhaled chemicals are subjective, variable, and subject to
suggestibility bias. Suggestion and/or suggestibility bias effects were demonstrated in a
study in which people given positive information about odors to which they were exposed
had less perceived irritation compared to people given negative information.7 In another
study, reports of sensory irritation in the workplace were influenced by the reactions of coworkers and other bystanders to an odor.16 Instructing persons to attend to evidence of
“nasal obstruction” as they breathed induced more symptoms than instructing them to attend
to the “free passage of air.” A significant amount of the variation in irritant and symptom
perception in normal, healthy individuals can be attributed to differences in personality
orientations. Positive affective orientations appear to lower individuals' expectancies of
3

becoming ill, while negative orientations appear to heighten those same expectancies.2
Although psychiatric causes may be an important source for symptoms, studies of patients
with multiple chemical sensitivity showed no psychiatric diagnosis in up to 50%.13
Demographic studies have shown that women, persons of relatively higher socioeconomic
status, and in office rather than heavy industry positions are more likely to report symptoms
from inhaled irritants.17 It is not understood why workers in heavy industry, who intuitively
would have greater exposure to airborne chemicals, have less reported symptoms.
Physiology affects irritant and odor perception. Irritants typically obey a sigmoid doseresponse relationship with a threshold under which no irritation reaction occurs. Many
toxicological irritants show reversible effects – the inflammation disappears after exposure
to the irritant ceases, however, acute exposures to high levels of some irritants can result in
irreversible effects.9, 18 Human physiology can also affect this perception, as experiments
have shown that odor intensity depends on the effort associated with inspiration.19
Interestingly, research shows that odors are perceived to be more pleasant and odor
identification is more accurate when smelled with the right nostril than with the left.20
Study limitations aside, there are at least three mechanisms by which ambient odors may
produce health symptoms. First, symptoms can be induced by exposure to odorants at levels
that also cause irritation or other toxicological effects. That is, irritation, rather than the
odor is the cause of the heath symptoms, and odor, the sensation, simply serves as an
exposure marker. Second, health symptoms from odorants at nonirritant concentrations can
be due to innate (genetically coded) or learned aversions. Third, symptoms may be due to a
copollutant (such as endotoxin) that is part of an odorant mixture.4 A problem has
developed, however, as there is a group of patients who have been given a diagnosis most
commonly called Multiple Chemical Sensitivity. The incidence of Multiple Chemical
Sensitivity is said to be increasing.3, 17 It has been defined as, "an acquired disorder
characterized by recurrent symptoms, referable to multiple organ systems, occurring in
response to demonstrable exposure to many chemically unrelated compounds at doses far
below those established in the general population to cause harmful effects. No single widely
accepted test of physiological function can be shown to be correlated with the symptoms.”21
Media sources have sensationalized some aspects of this sensitivity by reporting on "sick
buildings" and "20th Century Disease." Once the media and legal system have reinforced to
the general public that a product is dangerous, scientific evidence that comes after this
process is not likely to be reassuring, and the misperception endures.22 Waddell's comments
in 1992 are still true. "The salient problem with MCS is that there is no consistent and
specific effect from exposure to any specific chemical. This does not allow for any
objective test for any disease entity that might be caused by the chemicals as indicated by
the theory of MCS. The effects of exposure to chemicals as defined today by MCS are
subjective, and no report is available to convincingly demonstrate that these effects would
not have occurred merely by chance."23
To summarize, odor and irritant perception is a complicated field of study, with
disagreement about case definition, prevalence, and methodological problems that exist on
4

physiological and psychological levels. It is obvious that this field needs more study in
order to answer the question, "… is it the agents or the responder?" To that end, we have
created a questionnaire to identify normal individuals who seem to develop more severe
symptoms from inhaled environmental odors, chemicals, and irritants. These individuals
may be suitable for further physiological studies in the Breath Laboratory at the University
of South Florida. Hopefully, this and further studies in this laboratory will help determine
the cause of symptoms in this troubled population.
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Methods
The Institutional Review Board of the University of South Florida reviewed the study
proposal and exempted the study from further review.
This study describes the development and implementation of a self-administered
questionnaire to demonstrate the frequency and severity of symptoms a normal adult
population recalls when queried about their experience with exposure to four commonly
encountered airborne odors and irritants -cigarette smoke, perfumes, automobile exhaust,
and paint fumes - and relates these responses to their responses to quality of life queries.
The questionnaire was presented to volunteers as part of a packet contained in a selfaddressed University of South Florida interoffice envelope from February 1, 2007, to
February 28, 2007. The envelope contained a cover letter (Appendix B), a 23 item
demographic and medical questionnaire (Appendix C), and a two page 42 item symptom
and quality of life questionnaire (Appendix D).
The symptom questionnaire was created with input from consultants of the College of
Industrial and Organizational Psychology at the University of South Florida, who have
reviewed the questionnaire for readability and structure. Quality of life items are derived
from intuitive queries in addition to selected items from the Centers for Disease Control
Prevention Health-Related Quality of Life 14 Item Measure's "Healthy Days Core
Module."24 These items were included since they have been validated in other studies and
increase the information contained in the data from ordinal to the interval level. The
medical questionnaire was used to define the study population after the results were
returned. It contained items concerning smoking history and medical and psychological
conditions that could cause interference with normal olfaction and irritant sensation, all of
which were used as exclusion criteria. The demographic portion of the questionnaire
obtained sex and age information. No personally identifiable information was obtained.
Information on age was used to study adults from 18 to 80 years old. The entire
questionnaire took about 10 minutes to present and complete.
The questionnaire itself asked respondents to rate their likelihood of agreement with
statements relating to symptoms they experienced when they encountered cigarette smoke;
strong smells; cologne, perfumes or scented candles; automobile exhaust; or paint fumes in
the past year. The responses were scored on a 5-point Likert scale (1 = almost never; 5 =
almost always). The questionnaire contained subscales for ear, nose, and throat, lower
respiratory, general, gastrointestinal, and neuropsychological symptoms. To simplify
symptom scoring, the form of the statements is such that agreement with the experience of
6

symptoms results in a higher Likert score. In that way, more agreement with the statements
resulted in higher raw symptom scores. In this questionnaire, two formats were compared to
each other to quantify quality of life. In one format, four items were on a Likert scale, and
in the other format based on the CDC items, 3 items were in a fill in the blank format, which
will be referred to henceforth as “CDC styled” items.
Volunteers were obtained by submitting the questionnaire to male and female staff and
students of the College of Public Health at the University of South Florida during business
hours, personally delivered by the Principal Investigator. A kiosk in the College of Public
Health was also used to attract volunteers from student and staff traffic in the lobby of the
College of Public Health, also attended by the Principal Investigator. A flyer on the kiosk
was used to attract attention and provide initial information to potential volunteers.
Professors allowed the questionnaire to be distributed to a class in two cases.
Using standard deviation from the mean to define "high" and "low" scores, Magnavita15 was
able to demonstrate a significant difference (p<0.001) in total symptom scores between
cacosmic and noncascomic patients in a population of 47 subjects. We proposed, then, to
obtain 50 included subjects by submitting 100 questionnaires, expecting to exclude about
half of the returned questionnaires.
Volunteers were asked to respond to the questionnaire and mail their results via inter-office
mail to the College of Public Health inbox, addressed to the principal investigator. The
subjects completed the questionnaire privately in order to minimize social acceptability bias.
A new pencil with the USF logo (value ≈ $0.50) was enclosed in the envelope with the
questionnaire to compensate respondents for their time to complete the questionnaire.
In order to protect the privacy of participants, exclusion from analysis was performed after
the questionnaires were returned. Responses were excluded if any of the items were
answered positively in the medical questionnaire, except for one item, #3, which asked if the
respondent considered themselves a healthy person. Items that were left blank on the
Medical and Demographic portion of the questionnaire were considered a positive response
and resulted in exclusion from the normal group. All raw data has been dated and filed in a
locked cabinet in the Respiratory Laboratory in the College of Public Health for two years,
and then destroyed. Respiratory Laboratory personnel will hold the key.
Quality of life was measured by 4 questions with Likert scales and with 3 questions using
CDC styled items. The responses on the Likert format were summed to achieve a quality of
life score, and the CDC styled questions were added to obtain another quality of life score.
The possible range of values for summed Likert responses is 4 to 20. The possible range of
values for the CDC styled scores was 0 to 90. Each of these scores were compared to total
symptom scores to determine the relationship between quality of life scores and total
symptom scores in response to inhaled odors, chemicals, and irritants, using simple linear
regression.
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Statistical calculations were performed using Microsoft Excel 2003. A symptom score with
a possible range of 29-145 was obtained by summing the symptom ratings for each included
subject. Scores for the five symptom groups were obtained by selecting the items
corresponding to each system and summing the responses by system.
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Results
Ninety-six questionnaires were submitted to volunteers, and 82 were returned. Fifty
respondents identified themselves as female, and 28 identified themselves as male. Four
respondents did not specify age or sex. Median age for all respondents was 31 years,
ranging from 17 to 73. (Table 1) For reference, all items were numbered from the first
demographic item, through the medical exclusion items, through the symptom items, and
through the final quality of life items. These numbers appear in the far left column in the
appended questionnaires.
Table 1: Demographic Summary for All Respondents
n Lowest Age Median Age Highest Age
82
17
31
73
All
28
18
33.5
73
Males
50
17
29
61
Females
Unspecified 4
The intended group of respondents for this study, the inclusion group, were obtained by
using the responses given on the Medical and Demographic Information page (Appendix C)
to obtain a population without major physiological or psychological disease between the
ages of 18 and 80. Four responses had data of such poor quality they were excluded on this
basis alone. Exclusion criteria removed 55 more responses, leaving 23 responses included
for further statistical analysis, which was called the normal sample. The inclusion group
consisted of 13 females, 9 males and one unspecified age and sex. The median age for all
normal respondents for which data was specified was 26, ranging from 18 to 47. (Table 2)
Table 2: Demographic Summary for Normal Respondents
n Lowest Age Median Age Highest Age
23
18
26
47
All
Males
9
18
28
38
Females
13
19
27
47
Unspecified 1
Total symptom scores for the inclusion group were derived from a Likert scale and thus
treated as ordinal variables. These scores ranged from 35 to 106, representing the sum of all
9

Likert responses to specific symptom queries. The median score is 63.5. The frequency
distribution of symptom scores is shown in Figure 1.
Figure 1: Histogram of Total Symptom Scores in Normal Respondents
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The quality of life scores for the inclusion group ranged from 4 to 10 on the Likert scaled
items, out of a possible range of 4 to 20, representing the sum of responses to each of the 4
Likert items. A histogram of the quality of life scores on the Likert scale is shown in Figure
2. Increasing values on the Likert scale represented diminishing quality of life.
Figure 2: Histogram of Likert Quality of Life Scores in the Inclusion Group
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The histogram in Figure 3 shows the frequency of responses to the fill in the CDC styled
quality of life scores in the inclusion group. Three responses from the above group of Likert
respondents were not included in Figure 3 due to missing data. Increasing QOL score is in
the direction of more days of disability.
Figure 3: Histogram of CDC Styled Quality of Life Scores
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The adjusted Spearman rank correlation = .463 for the relationship between Likert-type
items and the CDC styled items in the inclusion group. The scatter plot of the raw quality of
life scores is represented in Figure 4.
Figure 4: Scatter Plot of Likert versus CDC Styled Responses
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To show the relationship between quality of life score and symptom score, each of the two
types of quality of life (Likert and CDC styled) scores were compared to total symptom
scores in the normal patients. Again, there are three less comparisons in the CDC styled
comparison than the Likert formatted items due to missing data. The relationship between
the Likert styled items and symptom scores in normal patients yields an adjusted Spearman
rank correlation = .916. The scatter plot and the best fit regression line for these points are
in Figure 5.
Figure 5: Scatter Plot of Symptom Score versus Likert Quality of Life Scores
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When the CDC styled quality of life scores are compared with the symptom scores, the
regression function gives an adjusted Spearman rank correlation = 0.725. These data are
represented in Figure 6 with a trendline showing the best fit for the regression function
between the variables.
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Figure 6: Scatter Plot of Symptom Score versus CDC Styled Quality of Life Score
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The responses in each symptom group were averaged to give a system score, and the sum of
these averages gave an adjusted symptom score that adjusted for the number of items in each
symptom group, which ranged from 4 to 9 items. This controlled for the different weights
given to the total symptom score due to the different number of items in each symptom
group. The unadjusted and adjusted total symptom scores were very similar, with adjusted
Spearman correlation coefficient between the two scores = 0.99. The possible adjusted
symptom score ranged from 5 to 25. The 5 symptom groups were compared by relating
their average score to the adjusted symptom score. This was done for several subsets of the
responses, including the inclusion group, the excluded group, an “atopic group”, and
smokers. These populations are not necessarily exclusive. The excluded group consisted of
all responses between the ages of 18 and 80 that are not in the inclusion group. The “atopic
group” consists of all excluded responses that would have been in the inclusion group but
for a positive response to the items, “Do you get hay fever, seasonal allergies, or allergic
rhinitis?” or “Do you have eczema or hives?” Smokers were defined as those excluded, but
which would have been in the inclusion group except for a positive response on the items,
“Are you a smoker?” or “Have you smoked in the last 10 years?”. Adjusted Spearman
correlation coefficients for these relationship between the system symptom score and the
total adjusted symptom score are presented in Table 3. LoResp represents the lower
respiratory system, and NeuroP represents neuropsychological symptoms.
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Table 3: Correlation Coefficients of Symptom Group with Adjusted Symptom
Score
Normal Excluded
0.86
0.87
General
0.92
0.83
ENT
0.93
0.76
GI
0.66
0.91
LoResp
0.80
0.44
NeuroP
0.83
0.76
Average

Atopic
0.75
0.90
0.24
0.48
0.81
0.64

Smokers Average
0.73
0.80
0.91
0.89
0.89
0.71
0.95
0.75
0.62
0.67
0.82
0.76

The symptom scores of these patient groups were compared to the Likert and CDC styled
quality of life scores. The adjusted Spearman correlation coefficients for the Likert styled
items appear in Table 4, and for the CDC styled items in Table 5.
Table 4: Correlation Coefficients of Symptom Group with Likert Styled Quality
of Life Items
General
ENT
GI
LoResp
NeuroP
Average

Normal Excluded
0.84
0.79
0.89
0.86
0.88
0.70
0.49
0.90
0.80
0.77
0.78
0.80

Atopic
0.43
0.07
0.64
0.52
0.48
0.43

Smokers Average
0.81
0.72
0.85
0.67
0.82
0.76
0.82
0.68
0.77
0.70
0.81
0.71

Table 5: Correlation Coefficients of Symptom Group with CDC Styled
Quality of Life items
General
ENT
GI
LoResp
NeuroP
Average

Normal Excluded
0.65
0.11
0.72
-0.05
0.60
0.04
0.35
0.04
0.65
-0.19
0.59
-0.01

Atopic
-0.31
-0.33
-0.13
-0.46
-0.30
-0.31

Smokers Average
0.26
0.18
0.00
0.09
0.00
0.13
0.07
0.00
0.26
0.11
0.12
0.10

The Mann-Whtney U test was used to determine the probability that the distributions of the
different symptom groups in the different patient groups were different than that of the
inclusion group. The p values are presented in Table 6:
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Table 6: Probability of Difference from Inclusion Group
General
ENT
GI
LoResp
NeuroP

Excluded
0.00
0.01
0.31
0.10
0.27

Atopic
0.23
0.01
0.25
0.49
0.22

Smokers
0.08
0.19
0.73
0.07
0.07

Items # 25 – 28 asked about respondents' reaction to cigarette smoke, automobile exhaust,
strong smells, cologne, perfumes or scented candles, and fresh paint vapors or fumes (the
substances in the table below). These responses were summed and compared with the
symptom scores of the different patient groups. The adjusted Spearman correlation
coefficients are shown in Table 7:
Table 7: Correlation Coefficients of Substances with Patient Groups
Normal Excluded
0.21
0.49
Cigarette
0.12
0.40
Exhaust
0.11
0.50
Scents
0.18
0.50
Paint

Atopic
0.48
0.23
0.60
0.47

Smokers
0.27
0.17
0.52
0.27

General health was queried twice, using two different formats. The first format gave a
yes/no choice, and the second gave a 5 level Likert range of responses. In all cases, items
answered "yes" to the query whether the respondent considered themselves a healthy person
were answered from 1-3 in the Likert scale, representing excellent, very good, and good
health. All "no" answers in the yes/no format were answered from 4 to 5 in the Likert
representation of the query, representing fair or poor health. The adjusted Spearman
correlation coefficient of this relation = .363.
There was a group of 15 respondents who were labeled "atopic", as they were excluded from
the normal group only by their positive response to the items on the medical portion of the
questionnaire relating to asthma, antihistamine use, hay fever, and eczema. The median
symptom score for this “atopic” group was 65 (n = 15), and it was 54 (n = 23) for the normal
group. Wilcoxon's two group rank-sum method25 was used to test the hypothesis that the
means of the groups were the same. The difference in the groups was significant for the two
tailed test at α = 0.1, with obtained t = 3.53 and critical t = 2.673.
The Mann-Whitney U test was used to determine the likelihood that patient groups’
distribution of symptom scores and quality of life scores (on the two different quality of life
styles) differed from the inclusion group scores. These are presented in Tables 8 and 9.
15

Table 8: Probability of Different Distribution from Inclusion Group Symptom
Scores
Excluded
Atopic
Smokers

0.23
0.16
0.03

Table 9: Probability of Different Distribution from Inclusion Group
Quality of Life Scores
Excluded
Atopic
Smokers

LQOL
0.40
0.30
0.12

CQOL
0.37
0.39
0.28

Symptom scores for males were significantly less than those for females only in the
inclusion group, with a one tailed p = 0.048. This same test shows that the mean symptom
scores are not significantly different for males and females in the normal group, where p =
0.5 for the difference.
The adjusted Spearman’s rank correlation coefficient relating age with total symptom scores
= .239 in the normal group and = -.054 in the excluded group.
Item # 24 asked respondents to identify their agreement with the statement, "I am more
sensitive to inhaled chemicals, irritants, odors, or strong fragrances than the average person."
The adjusted Spearman’s rank correlation coefficients relating the response to this single
item to the symptom groups in the different patient groups in Table 10.
Table 10: Correlation coefficients between Item 24 and Symptom Group in Various
Patient Groups
Normal Excluded
0.30
0.41
General
0.54
0.39
ENT
0.38
0.27
GI
0.09
0.45
LoResp
0.36
0.46
NeuroP
0.33
0.40
Average
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Atopic
0.47
0.43
-0.04
0.42
0.69
0.40

Smokers Average
-0.03
0.29
0.36
0.43
0.42
0.26
0.47
0.36
0.17
0.42
0.28
0.35

Discussion
Demographic comparison showed a similar age distribution between males and females, but
female respondents numbered twice those of males, reflecting the student population of the
College of Public Health at the University of South Florida.
The statistical analysis of the data in this cross-sectional study show that there is a bimodal
distribution of symptom scores that adults between the ages of 18 and 80 without
confounding disease states (the inclusion group) reports on their experience with cigarette
smoke, automobile exhaust, strong smells, cologne, perfumes or scented candles or fresh
paint vapors or fumes. This could represent a physiologic difference in individuals in the
two groups, the normal individuals without symptoms and the normal individuals with
symptoms. The nadir of the curve between modes provides a good point to divide "normal asymptomatic" and "normal - symptomatic" responses. This point would be a total
symptom score somewhere between 65 and 70, as this score seems to discriminate between
the groups on gross inspection of the histogram of symptom scores.
The quality of life scores obtained from the Likert scale items in this included group
correlate fairly well with symptom scores, whereas the quality of life scores from the fill in
the blank items correlate less well with symptom scores. Also, the quality of life scores
from the two different item formats correlate poorly with each other. None of the system
subscores agreed well with the CDC styled quality of life in any patient group other than the
inclusion group.
The hypothesis that increasing symptoms affects the health-related quality of life was
supported, as shown in Figures 5 and 6, where the regression slope is not zero, but is
positive in this case. This shows that increasing symptoms result in decreased health related
quality of life perceptions.
On average, of all the symptom categories, ear, nose, and throat symptoms correlated best
with total symptom scores, and neuropsychological symptoms correlated least well. High
correlation of the total symptom score with ENT symptoms may result from the fact that this
system is likely evolved to detect inhaled odors, chemicals, and irritants.
Interestingly, the quality of life scores for the atopic individuals was very poorly correlated
with quality of life. Perhaps the symptoms of atopy have incorporated into the background
sensations of these individuals to the point that these symptoms are not perceived as severe
enough to report.
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The only patient group system scores that differed at the 0.05 level of significance from the
inclusion group was the General and ENT scores in excluded respondents and ENT scores in
the atopic group.
Item # 24, regarding the overall question regarding one’s perceived sensitivity to odors,
chemicals, and irritants correlated fairly well with final symptom scores in all groups.
Magnavita, in his study of odor sensitivity in healthy workers, asked food store workers to
rate the likelihood that each of 10 substances were able to cause them symptoms of physical
illness. He found that self-identified odor intolerance was significantly associated with the
frequency of physical symptoms. Pearson product-moment calculations in the present study
agree with this conclusion, finding a coefficient = 0.55 between the item asking if an
individual considered himself sensitive to odors, chemicals, and irritants, and their total
symptom score. He also found that females developed symptoms more frequently than
males without regard to preexisting disease. A similar analysis of our data shows the same
effect when exclusions in this study are not applied, similar to his method.
Comparisons between similar information asked at different points or asked a different way
are useful to assess internal validity. There was agreement in direction of the answers to the
items. All those who felt they were generally healthy also agreed that they enjoyed good to
excellent health. All those who felt they were not generally healthy later agreed that they
suffered fair or poor health.
Biases in this questionnaire implementation include a severe selection bias. This study
sample represents a mostly young, ambulatory, healthy, educated population. This reflects
the environment in which it was distributed. Males and females are not represented equally.
The ethnic characteristics of this sample are not quantitatively known, but qualitatively, it
can be said that the respondents were of several different ethnicities, including African,
Caucasian, Hispanic, Black American, and Asian, with Caucasian representing the great
majority of respondents. This will affect external generalization. As experience with the
questionnaire grows, and the population to which it is submitted broadens, external
generalizability will become more possible.
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The Final Questionnaire
This questionnaire was a pilot study to create a final questionnaire to inexpensively identify
normal respondents who may suffer from symptoms when exposed to inhaled odors,
chemicals, and irritants in a stronger way than other normal individuals. This is to select
those for physiological testing that are more likely to demonstrate a physiological difference
when tested by inhalation challenge, which satisfies in part the ethical duty to minimize risks
to those not likely to benefit from investigation.
After analysis of this pilot questionnaire, it can be simplified and it needs modification.
Several respondents reflected the teaching in the College of Public Health that sex does not
equal gender, and the more appropriate question in this item would be gender.
Item # 3, asking, “Do you consider yourself a healthy person?”, can be dropped, as it is such
a general query it should not result in inclusion or exclusion in the normal group; that is, a
volunteer’s responses should not be segregated into the exclusion group if this were the only
item answered positively on the medical questionnaire of exclusion criteria.
Only one respondent reported an abnormal sense of taste and a normal sense of smell. All
other cases would have been excludable on the basis of abnormal sense of smell only. Also,
the sense of taste is not critical to sensations of odors, chemicals, and irritants, so it (Item #
11) can be dropped.
Consideration should be given to dropping the item on heart disease (Item # 14). The item
asking about heart medication should be more specific, as some respondents may consider
antihypertensive medication to be "heart medication", yet hypertension per se does not
indicate heart disease. This problem is magnified by the relatively high prevalence of
antihypertensive treatment compared to the prevalence of significant heart disease. If Item #
14 is kept, it should be preceded by an item asking about hypertension, such as "Do you take
medicine for high blood pressure?". Also, it is not critical that persons with heart disease are
excluded from the normal group, as there is no known link between heart disease and
perception of inhaled odors, chemicals, and irritants. Excluding respondents on the basis of
this disease may be too restrictive.
The item regarding psychiatric disorders (Item # 19) should be more specific to definitely
include those suffering from depression, which has been shown to influence responses to
inhaled odors. Antidepressant therapy could be used as a proxy for the diagnosis of
significant depression. It would be more accurate than self-diagnosis of depression without
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developing another questionnaire to merely establish this point. The proposed items for this
medical item are A: "Do you take medicine for depression?" and B: "Do you suffer from
any other psychiatric disorder?" A positive response to either should result in exclusion
from the normal group.
Near-identical responses to similar symptoms can be simplified by throwing out one or the
other. These are the burning (Item # 31) and tingling (Item # 32) of the face items. They
elicited identical responses, and therefore one is predictive of the other 100% of the time, so
either can be discarded. As few agreed with either statement, both could be dropped.
Item # 61 is moved upward in the item bank to follow the other symptoms and allow the
quality of life items to finish the section in order to ease analysis and scoring.
Two scales were tested to indicate quality of life. The Likert styled items, as they correlated
more closely with symptom scores than the CDC styled items, should be used if quality of
life is to be measured in the future. Therefore, in the final version, Items # 62-65 are
dropped.
(Appendix E) The final exclusion panel changes are shown in gray. It will consist of 20
items, including age and gender. The final symptom questionnaire, excluding quality of life
items, will consist of 33 items. It is expected that, using the considerations above, this
simpler questionnaire will retain the ability of the pilot questionnaire to detect the frequency
and severity of symptoms reported by normal individuals on their experience with odors,
chemicals, and irritants, and relate that with their quality of life.
As the items that were excluded from the symptom queries were mostly removed due to low
prevalence of positive responses, the dividing symptom score between normal and
responsive normal subjects can continue to be somewhere between 65 and 70 until the
distributions are better defined for the symptom scores.
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Appendix A: Flyer.
Formatting altered to fit format constraints.

A Questionnnaire and 15 minutes could
score you a shiny new
USF pencil!
Pencil Image

Details here

Appendix B: Cover Letter
To the volunteer:
I am inviting you participate in a research project to study symptoms that one develops after
exposure to airborne irritants. Along with this letter is a short questionnaire that asks a
variety of questions about this. I am asking you to look over the questionnaire and, if you
choose to do so, complete it and send it back to me using the interoffice envelope in which it
came. It should take you about 15 minutes to complete.
The results of this project will be used to refine this questionnaire so it can be used to
identify subjects for further study. Through your participation, I hope to identify those
questions that are most and least useful. The development and results of this study will be
used as the subject of my Masters Thesis in the College of Public Health.
I do not know of any risks to you if you decide to participate in this survey, and I guarantee
that your responses will not be identified with you. I promise not to share any information
that identifies you with anyone. You should not volunteer to put your name or any other
information on the questionnaire other than that which is requested. If you do not feel
comfortable completing the survey, discard it.
The survey should take you about 15 minutes to complete. I hope you will take the time to
complete this questionnaire and return it. Your participation is voluntary, and there is no
penalty if you do not participate. Regardless of whether you choose to participate, the
results will be on file at the University of South Florida Shimberg Health Sciences Library
after April 7, 2007.
If you have any questions or concerns about completing the questionnaire or about being in
this study, you may contact me at (813) 943-7960. Alternatively, if you have questions
about your rights, general questions, complaints, or issues as a person taking part in this
study, you may also call the Division of Research Integrity and Compliance of the
University of South Florida at (813) 974-9343.
Sincerely, and thank you,
signature
Stephen E. Williamson, M.D.
Chief Investigator
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Appendix C: Medical and Demographic Information.
Formatting altered to fit format constraints.
Demographics and History

1

Sex

2

Age

Please place an "X" in the appropriate box below
Yes
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

Do you consider yourself a healthy person?
Do you take antihistamines?
Do you get hay fever, seasonal allergies, or allergic rhinitis?
Do you cough every day?
Do you suffer from respiratory problems?
Do you have asthma?
Are you a smoker?
Do you have a normal sense of smell?
Do you have a normal sense of taste?
Have you smoked in the last 10 years?
Have you received systemic steroids or antibiotics within the past 4
weeks?
Do you have congestive heart failure, cardiomyopathy, valvular
heart disease, angina, cardiac arrhythmia, or had a myocardial
infarction within the last 6 months?
Are you taking heart medication?
Do you have hepatitis or cirrhosis?
Do you suffer from renal failure?
Do you suffer from any neurologic disorder?
Do you suffer from any psychiatric disorder?
Are you pregnant or think you might be?
Do you have eczema or hives?
Do you have arthritis?
Has a doctor ever told you that you have fibromyalgia, chronic
fatigue syndrome, or multiple chemical sensitivity?
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No

Appendix D: Symptom and Quality of Life Questionnaire.
Formatting altered to fit format constraints.
Chemical, Odorant And Irritant Sensitivity Questionnaire
This questionnaire asks about how you feel now and over the past year.
Please check the box that most closely describes how you feel.

24

25
26
27
28

29
30
31
32
33
34
35
36
37

Strongly
Disagree

Disagre
e

Uncertai
n

Agree

Stron
gly
Agree

Nothing
unusual

I am
bothere
d

A mild
reaction

Become
somewhat ill

Beco
me
very
Ill

I am more sensitive to inhaled
chemicals, irritants, odors, or
strong fragrances than the
average person

If I am around the following I
get this reaction:
Cigarette smoke
Automobile exhaust
Strong smells, cologne, perfumes
or scented candles
Fresh paint vapors or fumes

If I am exposed to cigarette smoke, automobile exhaust, strong smells, perfumes or
colognes, or fresh paint vapors:
Strongly Disagre
Uncertai
Agree
Stron
Disagree
e
n
gly
Agree
I suffer discomfort
I become sick
I develop burning in the skin of
my face
I develop tingling in the skin of my
face
I develop a funny sensation of the
skin of my face
I develop eye irritation
I develop eye pain
I develop eye itching
I develop sore or burning nasal
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38
39
40
41
42
43
44
45
46
47
48

49
50
51
52
53
54
55
56
57
58
59
60
61

passages
I develop burning in my nasal
passages
I develop a sore throat
I feel nauseated
I develop indigestion
I develop diarrhea
I get gas
I may cough
I may cough phlegm up
I feel like I can't get my breath.
I start wheezing
I feel tightness or pressure in my
chest

Continued on next page
If I am exposed to cigarette smoke, automobile exhaust, strong smells, perfumes or
colognes, or fresh paint vapors:
Strongly Disagre
Uncertai
Agree
Stron
Disagree
e
n
gly
Agree
I develop aching joints
I develop trouble sleeping
I develop numbness or tingling in
my hands or feet
My body feels hot or cold
I become emotional
I get a headache
I become anxious
I have trouble concentrating
I miss work
I miss social or business
appointments
I feel stress at home or work
I find it hard to interact with other
persons
My symptoms ease if I can get
away

Excellent
62

Would you say that in general
your health is:

29

Very
good

Good

Fair

Poor

63

64

65

Now thinking about your physical
health, which includes physical
illness and injury, for how many
days during the past 30 days was
your physical health not good?
Now thinking about your mental
health, which includes stress,
depression, and problems with
emotions, for how many days
during the past 30 days was your
mental health not good?
During the past 30 days, for about
how many days did poor physical
or mental health keep you from
doing your usual activities, such
as self-care, work, or recreation?
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Appendix E: Proposed Revised Medical and Demographic Information
Demographics and History

1

Sex Gender

2

Age

Please place an "X" in the appropriate box below
Yes
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23

Do you consider yourself a healthy person?
Do you take antihistamines?
Do you get hay fever, seasonal allergies, or allergic rhinitis?
Do you cough every day?
Do you suffer from respiratory problems?
Do you have asthma?
Are you a smoker?
Do you have a normal sense of smell?
Do you have a normal sense of taste?
Have you smoked in the last 10 years?
Have you received systemic steroids or antibiotics within the
past 4 weeks?
Do you have congestive heart failure, cardiomyopathy, valvular
heart disease, angina, cardiac arrhythmia, or had a myocardial
infarction within the last 6 months?
Are you taking heart medication?
Do you have hepatitis or cirrhosis?
Do you suffer from renal failure?
Do you suffer from any neurologic disorder?
Do you suffer from any psychiatric disorder?
Do you take medication for depression?
Are you pregnant or think you might be?
Do you have eczema or hives?
Do you have arthritis?
Has a doctor ever told you that you have fibromyalgia, chronic
fatigue syndrome, or multiple chemical sensitivity?
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No

Appendix F: Proposed Revised Symptom and Quality of Life Questionnaire
Chemical, Odorant And Irritant Sensitivity Questionnaire
This questionnaire asks about how you feel now and over the past year.
Please check the box that most closely describes how you feel.

24

25
26
27
28

29
30
31
32
33
34
35
36
37
38

Strong
ly
Disagr
ee

Disa
gree

Unce
rtain

Agree

Strongly
Agree

Nothin
g
unusu
al

I am
both
ered

A
mild
react
ion

Become
somewhat ill

Become
very Ill

I am more sensitive to inhaled
chemicals, irritants, odors, or
strong fragrances than the
average person

If I am around the following I get
this reaction:
Cigarette smoke
Automobile exhaust
Strong smells, cologne, perfumes
or scented candles
Fresh paint vapors or fumes

If I am exposed to cigarette smoke, automobile exhaust, strong smells,
perfumes or colognes, or fresh paint vapors:
Strong Disa Unce
Agree
Strongly
ly
gree rtain
Agree
Disagr
ee
I suffer discomfort
I become sick
I develop burning in the skin of my
face
I develop tingling in the skin of my
face
I develop a funny sensation of the
skin of my face
I develop eye irritation
I develop eye pain
I develop eye itching
I develop sore or burning nasal
passages
I develop burning in my nasal
passages
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39
40
41
42
43
44
45
46
47
48

I develop a sore throat
I feel nauseated
I develop indigestion
I develop diarrhea
I get gas
I may cough
I may cough phlegm up
I feel like I can't get my breath.
I start wheezing
I feel tightness or pressure in my
chest

61

Continued on next page
If I am exposed to cigarette smoke, automobile exhaust, strong smells,
perfumes or colognes, or fresh paint vapors:
Agree
Strongly
Strong Disa Unce
ly
gree rtain
Agree
Disagr
ee
I develop aching joints
I develop trouble sleeping
I develop numbness or tingling in
my hands or feet
My body feels hot or cold
My symptoms ease if I can get
away
Moved from item 61 to new position
I become emotional
I get a headache
I become anxious
I have trouble concentrating
I miss work
I miss social or business
appointments
I feel stress at home or work
I find it hard to interact with other
persons

62

Delete the following if quality of life is assessed. Use above Likert styled
items, # 58-61
Excell
Very
Goo
ent
good
d
Fair
Poor
Would you say that in general your
health is:

49
50
51
52
53
54
55
56
57
58
59
60

63

Now thinking about your physical
health, which includes physical
illness and injury, for how many
days during the past 30 days was
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your physical health not good?

64

65

Now thinking about your mental
health, which includes stress,
depression, and problems with
emotions, for how many days
during the past 30 days was your
mental health not good?
During the past 30 days, for about
how many days did poor physical
or mental health keep you from
doing your usual activities, such
as self-care, work, or recreation?
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